Back

Efficacy of smart device heart rhythm monitoring to detect spontaneous conversion to sinus rhythm in patients scheduled for electric cardioversion of atrial fibrillation. Kardiover Study.

7 April 2024 (16:30 - 17:15)
Organised by: Logo
Congress Presentation Part of: Arrhythmias 6: atrial fibrillation Wearables and m-Health EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Juan Benezet Mazuecos

La Luz University Hospital, Madrid (Spain)

7 More presentations in this session

Presentation thumbnail
Associations between atrial epicardial fat quantified by semi-automated CT segmentation and gender, BMI, cholesterol levels in AF patients: results from the prospective AFAT study
Doctor N. Erhard (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Clinical features and prognosis according to genotype variation in hypertrophic cardiomyopathy
Professor Y. Oh (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Gender-specific aspects of long-term CryoPVI efficacy
Doctor M. Rothe (Wiesbaden, DE)
Abstract Slides Video
Presentation thumbnail
Posterior wall isolation in patients with persistent atrial fibrillation: a single center comparative study between ablation index and very high power short duration radiofrequency ablation protocol
Doctor G. Negro (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Electrogram dispersion mapping for repeat ablation in patients with persistent atrial fibrillation
Mr A. Khan (Los Angeles, US)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmias 6: atrial fibrillation

The Event

Event poster

EHRA 2024

7 April 2024 16:30 CET
You may be interested in
thumbnail
Congress Presentation
Digital devices for heart rhythm monitoring in atrial fibrillation patients scheduled for elective electrical cardioversion. Kardiover study.
thumbnail
Congress Presentation
Stroke volume assessment by pocus in patients with heart failure undergoing electrical cardioversion to reverse atrial fibrillation to sinus rhythm
thumbnail
Congress Presentation
Smartphone application-based heart rhythm management around cardioversion in patients with presumed persistent atrial fibrillation: feasibility substudy of TeleConvert-AF

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources